Krónikus obstruktív tüdőbetegség (COPD): vizsgálatok itt: Franciaország
47 of 64 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleeValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- Where
- Aix En Provence, Amiens Cedex 1, Caen Cedex 9, Grenoble Cedex 9, Montivilliers, Nancy Cedex, Nice, Nimes Cedex 9
- Életkor
- 40 év to 75 év
- People
- 1196 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07177339 · EU 2025-521108-23-00 - 3. fázisTaking peopleEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Where
- Brest, La Tronche, Le Chesnay, Le Mans, Lyon, Montpellier, Pessac, Pontoise, Reims, Saint-Priest-en-Jarez, Suresnes, Vandœuvre-lès-Nancy
- Életkor
- 40 év to 80 év
- People
- 942 worldwide
- Run by
- Sanofi
See details and how to joinNCT07190209 · EU 2024-518016-39-00 - No phaseTaking peopleTime of Exercise Re-training With Chronic Obstructive Pulmonary Disease (COPD)
- Where
- Lille
- Életkor
- 18 év to 85 év
- People
- 90
- Run by
- Michaël RACODON
See details and how to joinNCT06366113 - 2. fázisNot yet taking people in FranciaországA Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Where
- Grenoble Cedex 9, Montpellier, Nice
- Életkor
- 40 év to 80 év
- People
- 402 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT07725939 · EU 2026-525523-25-00 - No phaseNot yet taking people in FranciaországThe Aim of the Study is to Decipher the Alterations in Signalling Pathways of Skeletal Muscle Stem Cells (Satellite Cells (SCs)) in Individuals With COPD, as Well as to Examine the Effect of Exercise Training on SCs.
- Where
- Créteil, Paris, Pessac
- Életkor
- 18 év to 75 év
- People
- 26
- Run by
- University Hospital, Bordeaux
See details and how to joinNCT07923656 - 2. fázisTaking peopleA Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Where
- Brest, Cholet, Créteil, La Tronche, Lyon Cedex 04, Marseille, Montpellier, Paris, Pessac, Toulouse, Vandoeuvre Les Nancy Cedex
- Életkor
- 40 év to 75 év
- People
- 606 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07759245 · EU 2026-525480-41-00 - No phaseTaking peopleEvaluation of Impaired Mobility in Chronic Illness Constitution of a Cohort
- Where
- Clermont-Ferrand
- Életkor
- 18 év to 90 év
- People
- 5000
- Run by
- University Hospital, Clermont-Ferrand
See details and how to joinNCT04375280 - No phaseTaking peopleCombinaison of Virtual Reality and Rehabilitation to Improve Muscle Function, Exercise Tolerance, Exertional Symptoms and Dyspnea in Patients With Chronic Respiratory Disease: a Randomized Cross-over Trial
- Where
- Paris
- Életkor
- 18 év and over
- People
- 26
- Run by
- Fondation Hôpital Saint-Joseph
See details and how to joinNCT06811402 - No phaseNot yet taking people in FranciaországImpact of Multidisciplinary Care, Structured and Targeted on the COPD Patient's Clinical Pathway.
- Where
- Nîmes
- Életkor
- 18 év and over
- People
- 116
- Run by
- Centre Hospitalier Universitaire de Nīmes
See details and how to joinNCT07907601 - 3. fázisNot yet taking people in FranciaországA Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- Where
- Lyon Cedex 02, Pessac
- Életkor
- 18 év to 80 év
- People
- 40 worldwide
- Run by
- Grifols Therapeutics LLC
See details and how to joinNCT07555483 · EU 2025-522792-29-00 - 2/3. fázisNot yet taking people in FranciaországA Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Where
- Epagny Metz-tessy, Lyon Cedex 04, Montpellier, Paris
- Életkor
- 35 év to 80 év
- People
- 1156 worldwide
- Run by
- Pfizer
See details and how to joinNCT07363694 · EU 2024-518587-12-00 - 4. fázisTaking peopleA Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- Where
- La Tronche, Lille, Lyon, Marseille, Montpellier, Pessac, Reims
- Életkor
- 40 év to 85 év
- People
- 218 worldwide
- Run by
- Sanofi
See details and how to joinNCT07053423 - 3. fázisTaking peopleLong-term Safety and Tolerability of Tozorakimab in Patients With COPD and History of Exacerbations
- Where
- Aix En Provence, Brest, Colmar Cedex, Epagny Metz-tessy, Grenoble Cedex 9, Lyon, Marseille, Montpellier Cedex 05, Pessac, Quimper Cedex, Saint-Herblain, Toulouse, Villefranche Sur Saone Cedex
- Életkor
- 18 év to 99 év
- People
- 59
- Run by
- AstraZeneca
See details and how to joinNCT07566195 · EU 2025-523690-41-00 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Where
- Brest, Lyon Cedex 04, Marseille, Montpellier, Paris, Paris Cedex 18, Pessac, Saint-Herblain, Strasbourg Cedex
- Életkor
- 40 év to 80 év
- People
- 990 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06878261 · EU 2024-517457-27-00 - 3. fázisTaking peopleDepemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- Where
- Amiens, Amiens Cedex 1, Blois Cedex, Caen, Grenoble Cedex 9, Lyon Cedex 04, Marseille, Nice, Pessac, Quimper Cedex, Reims Cedex, Saint-Herblain, Toulouse, Villeurbanne Cedex
- Életkor
- 40 év to 80 év
- People
- 981 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06959095 · EU 2024-520418-22-00 - 3. fázisFut, nem toborozA Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Where
- Aix En Provence, Aurillac, Bayonne, Blois Cedex, Brest, Cannes Cedex, Cherbourg-En-Cotentin, Creteil Cedex, Grenoble Cedex 9, Laval, Le Coudray, Lomme Cedex, Lyon Cedex 04, Marseille, Mulhouse, Paris, Pessac, Pringy Cedex, Quint-Fonsegrives, Reims Cedex, Roscoff, Strasbourg Cedex, Trelaze, Vandoeuvre Les Nancy, Vannes, Villeurbanne
- Életkor
- 40 év to 80 év
- People
- 5250 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00 - No phaseTaking peopleComparison of Arterial and Capillary Blood Gas Analyses in Patients With Respiratory Distress Due to COPD or APE
- Where
- Nice
- Életkor
- 18 év and over
- People
- 65
- Run by
- Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07835945 - 4. fázisTaking peopleChronic Airway Disease, Mucus Rheology and Exacerbations
- Where
- Bordeaux, Montpellier, Toulouse
- Életkor
- 40 év to 85 év
- People
- 72
- Run by
- University Hospital, Montpellier
See details and how to joinNCT04339270 - No phaseTaking peopleSPARK: Supporting Physical Activity Through Reality-Augmented Knowledge in COPD
- Where
- Montivilliers
- Életkor
- 18 év and over
- People
- 42
- Run by
- Groupe Hospitalier du Havre
See details and how to joinNCT07837375 - No phaseTaking peopleAn Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Where
- Limoges, Paris, Strasbourg, Toulouse
- Életkor
- 40 év to 80 év
- People
- 200 worldwide
- Run by
- Pulmonx Corporation
See details and how to joinNCT06035120 - No phaseTaking peopleEffect of Exercise Order During Pulmonary Rehabilitation on Muscle Strength in Patients With COPD
- Where
- Reims
- Életkor
- 18 év and over
- People
- 138
- Run by
- CHU de Reims
See details and how to joinNCT07655011 - 3. fázisTaking peopleTadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
- Where
- Le Kremlin-Bicêtre
- Életkor
- 18 év to 85 év
- People
- 200
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05844462 - No phaseNot yet taking people in FranciaországTime Course of Respiratory Oscillometry Parameters During Nasal High-Flow Therapy in Stable Chronic Obstructive Pulmonary Disease
- Where
- Rouen
- Életkor
- 18 év to 85 év
- People
- 20
- Run by
- ADIR Association
See details and how to joinNCT07750613 - No phaseNot yet taking people in FranciaországAcute Muscular and Vascular Responses to a Single Session of Exercise With BFR in COPD
- Where
- La Tronche
- Életkor
- 45 év and over
- People
- 40
- Run by
- University Hospital, Grenoble
See details and how to joinNCT07668921 - 3. fázisBefejeződöttLong Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency
- Where
- Bron
- Életkor
- 20 év to 72 év
- People
- 290 worldwide
- Run by
- Grifols Therapeutics LLC
See details and how to joinNCT02796937 · EU 2024-513962-20-00